{"name": "ImmusanT",
 "permalink": "immusant",
 "crunchbase_url": "http://www.crunchbase.com/company/immusant",
 "homepage_url": "http://www.immusant.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@immusant.com",
 "phone_number": "",
 "description": "",
 "created_at": "Wed Dec 14 04:51:13 UTC 2011",
 "updated_at": "Wed Dec 14 04:56:44 UTC 2011",
 "overview": "\u003Cp\u003EImmusanT, Inc., a biotechnology company, develops diagnostics and therapeutics for the diagnosis and treatment of celiac disease. The company focuses on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that improve diagnosis and treatment. It develops Nexvax2, a therapeutic vaccine for treating, preventing, and diagnosing celiac disease. The company also develops a functional T-cell test to diagnose and monitor the maintenance of immune tolerance with peptide based therapy. ImmusanT, Inc. was incorporated in 2010 and is based in Cambridge, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       33],
      "assets/images/resized/0016/6330/166330v1-max-150x150.png"],
     [[250,
       55],
      "assets/images/resized/0016/6330/166330v1-max-250x250.png"],
     [[389,
       86],
      "assets/images/resized/0016/6330/166330v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director, Founder, CEO and President",
    "person":
     {"first_name": "Leslie",
      "last_name": "Williams",
      "permalink": "leslie-williams",
      "image": null}},
   {"is_past": false,
    "title": "CSO \u0026 CMO",
    "person":
     {"first_name": "Bob",
      "last_name": "Anderson",
      "permalink": "bob-anderson",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Maury",
      "last_name": "Matteodo",
      "permalink": "maury-matteodo",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$20M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.prnewswire.com/news-releases/immusant-raises-20-million-in-series-a-financing-to-advance-immunotherapeutic-and-diagnostic-for-celiac-disease-135496313.html",
    "source_description": "ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Vatera Healthcare Partners",
         "permalink": "vatera-healthcare-partners",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Broadway",
    "address2": "14th Floor ",
    "zip_code": "02142 ",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}